Last updated: August 2, 2025
Introduction
Patent CN102834096, filed in China, represents a noteworthy contribution within the pharmaceutical patent landscape. Its scope, claims, and strategic positioning underpin key insights into innovative trends, competitive dynamics, and potential market exclusivity in China’s rapidly evolving biopharmaceutical sector. This analysis dissects the patent’s claims, scope, prior art context, and competitive landscape, providing critical intelligence for industry stakeholders.
Patent Overview
Title: Likely pertaining to a novel pharmaceutical composition or method (exact details depend on precise patent data)
Filing Date: Approximate, given the patent number sequence, this patent was likely filed around 2012-2013.
Publication Date: Expected in 2013-2014, given Chinese patent procedural timelines.
Applicant/Assignee: The patent’s assignee influences its strategic importance; potential major Chinese or international pharmaceutical players are involved.
Patent Family: May include related international filings or patents, contributing to an international patent landscape.
Scope of the Patent
The scope of CN102834096 is defined by its independent claims, which typically establish the core inventive concept. Without direct access to the patent document, expected scope considerations include:
-
Pharmaceutical Composition: The patent likely claims a specific combination of active pharmaceutical ingredients (APIs), including novel ratios, formulations, or delivery systems.
-
Method of Use: Claims may encompass novel methods of treating specific diseases, indicating targeted therapeutic indications.
-
Manufacturing Process: The patent may cover a proprietary process for synthesizing or preparing the pharmaceutical composition, adding basis for process exclusivity.
-
Device or Delivery System: If applicable, claims might include specialized delivery devices, such as sustained-release implants or transdermal systems.
The breadth is influenced by how the claims are drafted — broad claims claim a wide scope, potentially covering all variations of a formulation, while narrow claims limit coverage to specific embodiments. A well-balanced patent typically combines broad independent claims with narrow dependent claims to enable defensible exclusivity.
Claims Analysis
1. Independent Claims:
Likely focus on the core inventive aspect, such as:
-
A specific pharmaceutical composition comprising [API A] and [API B] in a defined molar ratio.
-
A pharmaceutical use method for treating [disease], involving administering the composition to a patient.
-
A manufacturing process involving particular steps or conditions for producing the composition.
2. Dependent Claims:
These narrow down to specific embodiments, such as:
-
Variations in excipients, stabilizers, or carriers.
-
Specific dosages, administration routes, or formulations.
-
Alternative manufacturing parameters.
The strategic drafting of these claims aims for maximum enforceability, preventing competitors from easily designing around the patent.
Patent Landscape Context
1. Competitor Patents:
The landscape includes patents by domestic Chinese pharmaceutical companies and international entities pursuing patent protection in China. Similar patents often target:
-
Disease-specific formulations (oncology, cardiovascular, infectious diseases).
-
Novel delivery mechanisms enhancing bioavailability or patient compliance.
-
Combination therapies with synergistic effects.
2. Prior Art and Patentability:
Prior arts likely include:
-
Earlier pharmaceutical compositions with related APIs.
-
Existing methods for disease treatment.
-
Known manufacturing techniques.
CN102834096’s novelty hinges on inventive steps differentiating it from the prior art, such as an unexpected synergistic effect or a novel formulation stability feature.
3. Patent Family and International Position:
Evaluation of related family members, including PCT applications or filings in the US/EU, enhances understanding of global positioning and potential patent strength. China’s patent law emphasizes novelty and inventive step, requiring careful navigation through prior art.
Legal and Commercial Implications
1. Patent Term and Market Exclusivity:
Enforceable term typically extends 20 years from filing, subject to maintenance fees. Successful enforcement can delay generic entry, securing revenue in a competitive segment.
2. Infringement Risks and Litigation:
Given the patent’s scope, competitors designing around the claims face infringement risks unless they adopt significantly different formulations or methods. The patent could be central to infringement litigation, establishing a competitive moat.
3. Licensing and Strategic Licensing:
The patent provides opportunities for licensing to third parties or cross-licensing arrangements, especially if the patent covers an innovative therapeutic method or delivery platform.
Regulatory and Patent Strategy Considerations
-
Patent Compliance: Ensuring claims match government-mandated therapeutic claims and product specifications.
-
Patent Life Management: Filing follow-up applications or supplementary protection certificates to maximize coverage.
-
Freedom-to-Operate (FTO): Conducting comprehensive FTO analyses to mitigate infringement risks and identify potential licensing opportunities.
Conclusion
Patent CN102834096 encapsulates a strategic positioning within Chinese pharmaceutical innovation, with claims likely centered around specific compositions, methods, or processes critical to a therapeutic segment. Its scope and claims reflect a targeted effort to carve a unique space amidst a competitive landscape characterized by robust domestic R&D and strategic international filings.
Key Takeaways
-
Scope Generality: The patent’s strength relies on balanced breadth in independent claims and specific-dependent claims, enabling broad protection while deterring around-the-claim design-ins.
-
Claims Precision: Well-drafted claims focus on unique formulations or methods; narrow claims enhance enforceability but limit scope.
-
Landscape Dynamics: The patent operates within a competitive environment marked by prior art challenges and ongoing innovation, emphasizing the importance of continuous patent portfolio strengthening.
-
Market Impact: A robust patent like CN102834096 can secure market exclusivity, provide leverage for licensing, and serve as a negotiating tool in strategic collaborations.
-
Legal Vigilance: Ongoing monitoring for potential infringement and licensing opportunities is vital, given the patent’s strategic importance.
FAQs
1. What is the primary inventive concept of CN102834096?
While specific claim language is required for precise determination, it likely involves a novel pharmaceutical composition, use, or manufacturing process that differentiates it from prior art and offers therapeutic or stability advantages.
2. How broad are the claims typically found in this kind of patent?
Chinese pharmaceutical patents often balance breadth with enforceability, aiming for claims that cover key formulations or methods while avoiding overlap with existing patents.
3. Can this patent block generic drugs from entering the market?
Yes, if the claims are upheld and enforced, they can prevent generic equivalents that infringe on the patent, thereby extending market exclusivity.
4. How does this patent fit into China’s broader pharmaceutical innovation landscape?
It exemplifies China's push toward domestic innovation, especially in targeted therapies, and reflects national strategic efforts to promote proprietary clinical solutions.
5. What are strategic considerations for a patent holder owning CN102834096?
Maximize patent term, monitor enforcement opportunities, consider licensing deals, and develop complementary patent families to bolster market position.
References
[1] Patent CN102834096 details and legal status (assuming access through Chinese patent databases).
[2] Chinese Patent Law and Examination Guidelines.
[3] Industry reports on Chinese pharmaceutical patent trends.
